サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1387490

蛍光in situハイブリダイゼーション（FISH）市場レポート：2030年までの動向、予測、競合分析

Fluorescent in Situ Hybridization (FISH) Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

蛍光in situハイブリダイゼーション（FISH）市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年11月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

蛍光in situハイブリダイゼーション（FISH）の動向と予測

世界の蛍光in situハイブリダイゼーション（FISH）市場は、2024年から2030年までのCAGRが7.6%で、2030年までに推定18億4,000万米ドルに達すると予想されます。この市場の主な促進要因は、がんや遺伝性疾患の患者数の増加とFISH製品の継続的な進歩です。世界の蛍光in situハイブリダイゼーション（FISH）市場の将来は、がん研究、遺伝子研究、感染症、個別化医療市場における機会で有望視されています。

蛍光in situハイブリダイゼーション（FISH）市場洞察

Lucintelは、予測期間中、消耗品が最大のセグメントであり続けると予測しています。

この市場の中では、がんの有病率の増加とがん研究に対する政府支援の高まりにより、がん研究が最も高い成長を遂げると予測されます。

北米は、乳がんや感染症治療の研究開発への投資が増加しているため、予測期間中も最大地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の蛍光in situハイブリダイゼーション（FISH）市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018～2030年の市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の蛍光in situハイブリダイゼーション（FISH）市場動向（2018～2023年）および予測（2024～2030年）
  • 製品タイプ別の世界の蛍光in situハイブリダイゼーション（FISH）市場
    • 消耗品
    • 装置
    • ソフトウェア
  • 技術別の世界の蛍光in situハイブリダイゼーション（FISH）市場
    • DNA蛍光in situハイブリダイゼーション
    • RNA蛍光in situハイブリダイゼーション
    • PNA蛍光in situハイブリダイゼーション
    • その他
  • 用途別の世界の蛍光in situハイブリダイゼーション（FISH）市場
    • がん研究
    • 遺伝子研究
    • 感染症
    • 個別化医療
    • その他
  • 最終用途別の世界の蛍光in situハイブリダイゼーション（FISH）市場
    • 病院とクリニック
    • 診断研究所
    • 製薬およびバイオテクノロジー企業
    • 受託研究機関
    • 学術研究機関
    • その他

第4章 2018～2030年の地域別の市場動向と予測分析

  • 地域別の世界の蛍光in situハイブリダイゼーション（FISH）市場
  • 北米の蛍光in situハイブリダイゼーション（FISH）市場
  • 欧州の蛍光in situハイブリダイゼーション（FISH）市場
  • アジア太平洋の蛍光in situハイブリダイゼーション（FISH）市場
  • その他地域の蛍光in situハイブリダイゼーション（FISH）市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品タイプ別の世界の蛍光in situハイブリダイゼーション（FISH）市場の成長機会
    • 技術別の世界の蛍光in situハイブリダイゼーション（FISH）市場の成長機会
    • 用途別の世界の蛍光in situハイブリダイゼーション（FISH）市場の成長機会
    • 最終用途別の世界の蛍光in situハイブリダイゼーション（FISH）市場の成長機会
    • 地域別の世界の蛍光in situハイブリダイゼーション（FISH）市場の成長機会
  • 世界の蛍光in situハイブリダイゼーション（FISH）市場における新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の蛍光in situハイブリダイゼーション（FISH）市場の能力拡大
    • 世界の蛍光in situハイブリダイゼーション（FISH）市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Abnova Corporation
  • Agilent Technologies
  • Biocare Medical
  • Biodot
  • F. Hoffmann-LA Roche
  • Genemed Technologies
  • Merck
  • PERKINELMER
  • Qiagen
  • Thermo Fisher Scientific
目次

Fluorescent in Situ Hybridization (FISH) Trends and Forecast

The future of the global fluorescent in situ hybridization (FISH) market looks promising with opportunities in the cancer research, genetic research, infectious disease, and personalized medicine markets. The global fluorescent in situ hybridization (FISH) market is expected to reach an estimated $1.84 billion by 2030 with a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are rising cases of cancer and genetic diseases and on-going advancements in FISH products.

A more than 150-page report is developed to help in your business decisions.

Fluorescent in Situ Hybridization (FISH) by Segment

The study includes a forecast for the global fluorescent in situ hybridization (FISH) by product type, technology, application, end use, and region.

Fluorescent in Situ Hybridization (FISH) Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Consumables
  • Instrument
  • Software

Fluorescent in Situ Hybridization (FISH) Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • DNA Fluorescent in Situ Hybridization
  • RNA Fluorescent in Situ Hybridization
  • PNA Fluorescent in Situ Hybridization
  • Others

Fluorescent in Situ Hybridization (FISH) Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cancer Research
  • Genetic Research
  • Infectious Disease
  • Personalized Medicine
  • Others

Fluorescent in Situ Hybridization (FISH) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Pharmaceuticals & Biotechnology Companies
  • Contract Research Organisations
  • Academic & Research Organisations
  • Others

Fluorescent in Situ Hybridization (FISH) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Fluorescent in Situ Hybridization (FISH) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies fluorescent in situ hybridization (FISH) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the fluorescent in situ hybridization (FISH) companies profiled in this report include-

  • Abnova Corporation
  • Agilent Technologies
  • Biocare Medical
  • Biodot
  • F. Hoffmann-LA Roche
  • Genemed Technologies
  • Merck
  • PERKINELMER
  • Qiagen
  • Thermo Fisher Scientific

Fluorescent in Situ Hybridization (FISH) Market Insights

Lucintel forecasts that consumables will remain the largest segment over the forecast period.

Within this market, cancer research is expected to witness the highest growth due to increasing prevalence of cancer and rising government support for cancer research.

North America will remain the largest region over the forecast period due to growing investment in research and development of breast cancer and infectious disease treatment in the region.

Features of the Global Fluorescent in Situ Hybridization (FISH) Market

Market Size Estimates: Fluorescent in situ hybridization (FISH) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Fluorescent in situ hybridization (FISH) market size by various segments, such as by product type, technology, application, end use, and region in terms of value ($B).

Regional Analysis: Fluorescent in situ hybridization (FISH) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the fluorescent in situ hybridization (FISH) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the fluorescent in situ hybridization (FISH) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the fluorescent in situ hybridization (FISH) market size?

Answer: The global fluorescent in situ hybridization (FISH) market is expected to reach an estimated $1.84 billion by 2030.

Q2. What is the growth forecast for fluorescent in situ hybridization (FISH) market?

Answer: The global fluorescent in situ hybridization (FISH) market is expected to grow with a CAGR of 7.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the fluorescent in situ hybridization (FISH) market?

Answer: The major drivers for this market are rising cases of cancer and genetic diseases and on-going advancements in FISH products.

Q4. What are the major segments for fluorescent in situ hybridization (FISH) market?

Answer: The future of the fluorescent in situ hybridization (FISH) market looks promising with opportunities in the cancer research, genetic research, infectious disease, and personalized medicine markets.

Q5. Who are the key fluorescent in situ hybridization (FISH) market companies?

Answer: Some of the key fluorescent in situ hybridization (FISH) companies are as follows:

  • Abnova Corporation
  • Agilent Technologies
  • Biocare Medical
  • Biodot
  • F. Hoffmann-LA Roche
  • Genemed Technologies
  • Merck
  • PERKINELMER
  • Qiagen
  • Thermo Fisher Scientific

Q6. Which fluorescent in situ hybridization (FISH) market segment will be the largest in future?

Answer: Lucintel forecasts that consumables will remain the largest segment over the forecast period.

Q7. In fluorescent in situ hybridization (FISH) market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing investment in research and development of breast cancer and infectious disease treatment in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the fluorescent in situ hybridization (FISH) market by product type (consumables, instrument, and software), technology (DNA fluorescent in situ hybridization, RNA fluorescent in situ hybridization, PNA fluorescent in situ hybridization, and others), application (cancer research, genetic research, infectious disease, personalized medicine, and others), end use (hospitals & clinics, diagnostic laboratories, pharmaceuticals & biotechnology companies, contract research organisations, academic & research organisations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Fluorescent in Situ Hybridization (FISH) Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Fluorescent in Situ Hybridization (FISH) Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Fluorescent in Situ Hybridization (FISH) Market by Product Type
    • 3.3.1: Consumables
    • 3.3.2: Instrument
    • 3.3.3: Software
  • 3.4: Global Fluorescent in Situ Hybridization (FISH) Market by Technology
    • 3.4.1: DNA Fluorescent in Situ Hybridization
    • 3.4.2: RNA Fluorescent in Situ Hybridization
    • 3.4.3: PNA Fluorescent in Situ Hybridization
    • 3.4.4: Others
  • 3.5: Global Fluorescent in Situ Hybridization (FISH) Market by Application
    • 3.5.1: Cancer Research
    • 3.5.2: Genetic Research
    • 3.5.3: Infectious Disease
    • 3.5.4: Personalized Medicine
    • 3.5.5: Others
  • 3.6: Global Fluorescent in Situ Hybridization (FISH) Market by End Use
    • 3.6.1: Hospitals & Clinics
    • 3.6.2: Diagnostic Laboratories
    • 3.6.3: Pharmaceuticals & Biotechnology Companies
    • 3.6.4: Contract Research Organisations
    • 3.6.5: Academic & Research Organisations
    • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Fluorescent in Situ Hybridization (FISH) Market by Region
  • 4.2: North American Fluorescent in Situ Hybridization (FISH) Market
    • 4.2.2: North American Fluorescent in Situ Hybridization (FISH) Market by Application: Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Others
  • 4.3: European Fluorescent in Situ Hybridization (FISH) Market
    • 4.3.1: European Fluorescent in Situ Hybridization (FISH) Market by Product Type: Consumables, Instrument, and Software
    • 4.3.2: European Fluorescent in Situ Hybridization (FISH) Market by Application: Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Others
  • 4.4: APAC Fluorescent in Situ Hybridization (FISH) Market
    • 4.4.1: APAC Fluorescent in Situ Hybridization (FISH) Market by Product Type: Consumables, Instrument, and Software
    • 4.4.2: APAC Fluorescent in Situ Hybridization (FISH) Market by Application: Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Others
  • 4.5: ROW Fluorescent in Situ Hybridization (FISH) Market
    • 4.5.1: ROW Fluorescent in Situ Hybridization (FISH) Market by Product Type: Consumables, Instrument, and Software
    • 4.5.2: ROW Fluorescent in Situ Hybridization (FISH) Market by Application: Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by Technology
    • 6.1.3: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by Application
    • 6.1.4: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by End Use
    • 6.1.5: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by Region
  • 6.2: Emerging Trends in the Global Fluorescent in Situ Hybridization (FISH) Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Fluorescent in Situ Hybridization (FISH) Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Fluorescent in Situ Hybridization (FISH) Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abnova Corporation
  • 7.2: Agilent Technologies
  • 7.3: Biocare Medical
  • 7.4: Biodot
  • 7.5: F. Hoffmann-LA Roche
  • 7.6: Genemed Technologies
  • 7.7: Merck
  • 7.8: PERKINELMER
  • 7.9: Qiagen
  • 7.10: Thermo Fisher Scientific